NIH Cancels Funding for Bat Coronavirus Research Project

NIH Cancels Funding for Bat Coronavirus Research Project

The abrupt termination comes after the research drew President Trump’s attention for its ties to the Wuhan Institute of Virology.

ABOVE: The canceled grant included money for surveillance of coronaviruses in Yunnan, China.
© ISTOCK.COM, REDTEA

Update (May 26): Last week, 77 Nobel laureates and 31 scientific societies separately sent letters to NIH Director Francis Collins criticizing the decision to terminate the grant and urging that it be reviewed, Science reports.

A grant to a New York nonprofit aimed at detecting and preventing future outbreaks of coronaviruses from bats has been canceled by the National Institutes of Health, Politico reports, apparently at the direction of President Donald Trump because the research involved the Wuhan Institute of Virology in China. The virology institute has become a focal point for the idea that SARS-CoV-2 escaped from the laboratory and caused the current COVID-19 pandemic, a scenario experts say is not supported by evidence. Instead, virologists The Scientist has spoken to say the virus most likely jumped from infected animals to humans.

The grant, first awarded in fiscal year 2014 and most recently renewed last year, went to EcoHealth Alliance, which describes itself as “a global environmental health nonprofit organization dedicated to protecting wildlife and public health from the emergence of disease.” The aims of the funded project included characterizing coronaviruses present in bat populations in southern China and conducting surveillance to detect spillover events of such viruses to people. The project has resulted in 20 publications, most recently a March report on zoonotic risk factors in rural southern China.

See “Where Coronaviruses Come From

EcoHealth Alliance’s partners on the project include researchers at the Wuhan Institute of Virology, a BSL-4 facility that has for months been a focus of conspiracy theories that SARS-CoV-2 escaped or was released from a lab. On April 14, the The Washington Post published a column highlighting State Department cables about concerns regarding safety at the institute. (Experts tell NPR that, even in light of the cables, accidental escape of the virus from a lab remains a far less likely scenario than a jump from animals.) 

Then, in an April 17 White House coronavirus briefing, a reporter, whom Politico identifies as being from Newsmax, falsely stated in a question that “US intelligence is saying this week that the coronavirus likely came from a level 4 lab in Wuhan,” and that the NIH had awarded a $3.7 million grant to the Wuhan lab. “Why would the US give a grant like that to China?” she asked. “We will end that grant very quickly,” Trump said in his answer.

See “Theory that Coronavirus Escaped from a Lab Lacks Evidence

An NIH official then wrote to EcoHealth Alliance to inquire about money sent to “China-based participants in this work,” Politico reports, and the organization’s head, Peter Daszak, responded that a complete response would take time, but that “I can categorically state that no fund from [the grant] have been sent to the Wuhan Institute of Virology, nor has any contract been signed.” Days later, NIH notified EcoHealth Alliance that future funding for the project was canceled, and that it must immediately “stop spending the $369,819 remaining from its 2020 grant”—an unusual move generally reserved for cases of scientific misconduct or financial improprieties, according to Politico.

In a statement about the cancellation, EcoHealth Alliance says the terminated research “aimed to analyze the risk of coronavirus emergence and help in designing vaccines and drugs to protect us from COVID-19 and other coronavirus threats,” and that it addresses “all four strategic research priorities of the NIH/NIAID Strategic Plan for COVID-19 Research, released just this week.” The organization will, it says, “continue our fight against this and other emerging diseases.”

The Scientist's Current Issue's Magazine Cover

June 2020

An Infant's Bounty

Babies amass microbes that can pave the way to a healthy life

Protein Synthesis Enzymes Have Evolved Additional Jobs
Protein Synthesis Enzymes Have Evolved Additional Jobs
Protein Synthesis Enzymes Have Evolved Additional Jobs
Aminoacyl-tRNA synthetases, which help translate the genetic code into protein, also function in angiogenesis, fat metabolism, and more.
Left-Handed DNA Has a Biological Role Within a Dynamic Genetic Code
Left-Handed DNA Has a Biological Role Within a Dynamic Genetic Code
Left-Handed DNA Has a Biological Role Within a Dynamic Genetic Code
Once considered an unimportant curiosity, Z-DNA is now recognized to provide an on-the-fly mechanism to regulate how an RNA transcript is edited.
The Infant Gut Microbiome and Probiotics that Work
The Infant Gut Microbiome and Probiotics that Work
The Infant Gut Microbiome and Probiotics that Work
The gut microbiome is more malleable in the first two years after birth, allowing probiotics to make their mark. Can we exploit this to improve infants’ health?
Marketplace

Sponsored Product Updates

In-House Water Compared to Bottled HPLC-Grade Water
In-House Water Compared to Bottled HPLC-Grade Water
In-House Water Compared to Bottled HPLC-Grade Water
Download this application note to learn how in-house water is an effective option as an HPLC mobile phase!
Considerations to Ensure Optimal Isolation of Single Cells
Considerations to Ensure Optimal Isolation of Single Cells
Considerations to Ensure Optimal Isolation of Single Cells
This review article focuses on the upstream considerations for isolation of individual cells to yield optimal results in single cell applications.
Abingdon Health announces its latest expansion and additional manufacturing capacity
Abingdon Health announces its latest expansion and additional manufacturing capacity
Abingdon Health announces its latest expansion and additional manufacturing capacity
Abingdon Health is pleased to announce further expansion at its York headquarters in the UK, following further investment in state-of-the-art lateral flow automation.